 "Coronavirus, vaccine, covid, drugs, tests, clinical trials")
Amidst reports claiming Serum Institute of India would be ready with Covishield vaccine in 73 days, the Pune-based company on Sunday clarified that these claims were misleading.
“The government has granted us permission to only manufacture the vaccine and stockpile it for future use,” Serum Institute said on Sunday. The drugmaker said the vaccine would be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place. It said the claims surrounding Covishield's availability in the media were “conjectural”.
